Another attractive source of MSCs, human endometrial mesenchymal stem cells (EnSCs), also show an ability to decrease tumor growth and to increase angiogenesis in ovarian cancer by inhibiting AKT phosphorylation and decreasing expression of VEGFA and HIF-1α, possibly via nuclear translocation of FoxO3a [186]. This evidence concerns the gene AKT1 and neoplasm.